More U.S. adults using melatonin as sleep aid despite lack of evidence
Mar 04, 2022
Use of the supplement melatonin by U.S. adults has more than quintupled between 1999 and 2018, a new study has found.
Burden of persistent symptoms high after COVID-19 infection
May 24, 2022
– A high burden of persistent symptoms is observed in persons after COVID-19, but no specific causes of symptoms of postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)...
U.S. invests $1 billion in a vaccine candidate; NIH tests multiple COVID-19 treatments
By
Alicia Lasek
Aug 07, 2020
One hundred million doses of the experimental vaccine will be stockpiled. The deal increases the likelihood that the United States will have at least one safe, effective vaccine by 2021, HHS Secretary...
NIH panel updates treatment guidelines for non-hospitalized COVID-19 patients
By
Alicia Lasek
Jan 25, 2022
A new recommended treatments list addresses the omicron variant’s current dominance and drug supply shortages.
NIH releases COVID-19 treatment guidelines, warns against drug combo
By
Alicia Lasek
Apr 22, 2020
The comprehensive guidelines are posted in a “living document” that will be updated as new information and evidence emerges, the agency announced Tuesday.
New NIH network to recruit thousands for late-stage COVID-19 vaccine trials
By
Alicia Lasek
Jul 09, 2020
A nationwide clinical trial network will test promising COVID-19 vaccines and antibodies. There are five possible vaccine candidates.
Antigen tests just as effective as PCR in preventing COVID outbreaks, NIH study finds
By
Alicia Lasek
Jul 02, 2021
A “highly anticipated” study now shows that both testing approaches can give 98% sensitivity when used at least twice weekly in a screening program.
Robust response to virus variants expected in former COVID patients and the vaccinated
By
Alicia Lasek
Mar 31, 2021
Blood samples from recovered COVID-19 patients show that they and their vaccinated peers should be able to fend off the virus and its variants in future encounters, NIH researchers say.
U.S. to test vaccine combos for future anti-variant strategy, Fauci says
By
Alicia Lasek
Apr 01, 2022
The NIH is launching a phase 2 clinical trial to help determine which vaccine combos can provide a broader immune response in adults who have already had a series of COVID-19 vaccinations.
Fauci: ‘Pan-viral’ vaccine may be needed to tackle tenacious COVID-19 long-term
By
Alicia Lasek
Feb 16, 2021
The virus that causes COVID-19 likely is here to stay, and its success in humans means that stronger defense measures will be needed, say Anthony Fauci, M.D., and colleagues from the National Institute...